Trial Outcomes & Findings for Efficacy of Ginger on Intraoperative and Postoperative Nausea and Vomiting in Elective Cesarean Section Patients (NCT NCT01733212)
NCT ID: NCT01733212
Last Updated: 2021-09-10
Results Overview
Participants who had intra-operative and post-operative vomiting were identified and compared between the two groups.
COMPLETED
PHASE2/PHASE3
239 participants
During surgery (1 hour) and thru 72 hours after surgery
2021-09-10
Participant Flow
Enrollment period: June 03, 2010 to April 12, 2011 Location: New York Methodist Hospital, Department of Obstetrics and Gynecology
Participant milestones
| Measure |
Ginger
2 gm powder of ginger filled in a capsule
|
Placebo
2 gm of placebo pill (A capsule)
|
|---|---|---|
|
Overall Study
STARTED
|
116
|
123
|
|
Overall Study
COMPLETED
|
116
|
123
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Efficacy of Ginger on Intraoperative and Postoperative Nausea and Vomiting in Elective Cesarean Section Patients
Baseline characteristics by cohort
| Measure |
Ginger
n=116 Participants
2 gm powder of ginger filled in a capsule
|
Placebo
n=123 Participants
2 gm of placebo pill (A capsule)
|
Total
n=239 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
116 Participants
n=5 Participants
|
123 Participants
n=7 Participants
|
239 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
32.8 years
STANDARD_DEVIATION 5.3 • n=5 Participants
|
33.0 years
STANDARD_DEVIATION 4.8 • n=7 Participants
|
32.9 years
STANDARD_DEVIATION 5.0 • n=5 Participants
|
|
Sex: Female, Male
Female
|
116 Participants
n=5 Participants
|
123 Participants
n=7 Participants
|
239 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
116 participants
n=5 Participants
|
123 participants
n=7 Participants
|
239 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: During surgery (1 hour) and thru 72 hours after surgeryPopulation: Number of participants who had vomiting in each group is compared to the other group using Chi square test
Participants who had intra-operative and post-operative vomiting were identified and compared between the two groups.
Outcome measures
| Measure |
Ginger
n=116 Participants
2 gm powder of ginger filled in a capsule
|
Placebo
n=123 Participants
2 gm of placebo pill (A capsule)
|
|---|---|---|
|
Occurrence of Intra-operative and Post-operative Vomiting
|
30 Participants
|
45 Participants
|
Adverse Events
Ginger
Placebo
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place